Our curated list of the best biotechnology stocks is filtered using metrics for quality and growth. All the biotech stocks are traded on U.S. exchanges, have at least a $5 share price and trade at least 500,000 shares per day. In addition, they all meet the following requirements:
- Must generate sales. All stocks on this list must be generating sales via some approved product on the market.
- High expected growth rate. At the time of this list’s compiling, all of the included stocks were expected to grow EPS by an average of at least 9.5% per year over the next five years.
- Profitability. All the companies are profitable already or are expected to be this year based on analyst estimates.
- No major earnings drops. Companies with large expected drops in earnings this year or next were excluded.
All biotechnology stocks, regardless of the criteria used for selecting them, have very significant price volatility. This means they can see sizable price gains and losses over the short term.
The stocks above were selected by an experienced financial analyst, but they may not be right for your portfolio. Before you decide to purchase any of these stocks, do plenty of research to ensure they are aligned with your financial goals and risk tolerance.
Looking For A Financial Advisor?
Get In Touch With A Pre-screened Financial Advisor In 3 Minutes